Filing Details
- Accession Number:
- 0001209191-21-008132
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-05 16:52:16
- Reporting Period:
- 2021-02-03
- Accepted Time:
- 2021-02-05 16:52:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661567 | Michael Parini | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Adm, Leg & Bd Off | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-03 | 8,438 | $0.00 | 35,276 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2021-02-03 | 10,324 | $0.00 | 45,600 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2021-02-03 | 11,627 | $0.00 | 57,227 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2021-02-03 | 400 | $86.52 | 57,627 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-03 | 200 | $215.52 | 57,427 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-03 | 100 | $217.00 | 57,327 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-03 | 100 | $218.20 | 57,227 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy) | Disposition | 2021-02-03 | 400 | $0.00 | 400 | $86.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,930 | 2027-02-02 | No | 4 | M | Direct |
Footnotes
- Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2018 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest on 02/17/2021.
- Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest in installments beginning on 02/10/2021.
- Restricted stock unit award that vests in installments beginning on 02/17/2022.
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $215.52 (range $215.47 to $215.58).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
